The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Effectiveness, Cost-effectiveness And Equity Of Strategies To Reduce The Burden Of Obesity-related Conditions
Funder
National Health and Medical Research Council
Funding Amount
$46,900.00
Summary
Decision-makers need a systematic, coordinated approach to the targeting and prioritisation of preventive strategies. But the evidence base for obesity interventions is for the most part small, narrow in approach, limited in impact, and lacking in cost-effectiveness and equity information. This thesis will add to the evidence base regarding the nature of the obesity epidemic in Australia and internationally and the relative cost-effectiveness of strategies to reduce the obesity burden.
The Cost-effectiveness Of Early Resuscitation Of Sepsis In Australia - An Economic Evaluation Alongside The ARISE-RCT
Funder
National Health and Medical Research Council
Funding Amount
$115,971.00
Summary
Critical care treatment is expensive and consumes a significant portion of hospital resources. This study will collect cost, survival and quality of life data on a group of sepsis patients enrolled in a trial of strict protocolised treatment versus standard care (the ARISE study). This information will be used to determine how much it costs for each additional survivor with protocolised treatment, and how much it costs for each quality adjusted life year gained with protocolised treatment.